Skip to main content
  1. Right Decisions
  2. Maternity & Gynaecology Guidelines
  3. Maternity
  4. Back
  5. Common obstetric problems, intrapartum labour ward
  6. Caesarean Section (576)
Announcements and latest updates

Right Decision Service newsletter: April 2024

Welcome to the Right Decision Service (RDS) newsletter for April 2024. 

Issues with RDS and Umbraco access

Tactuum has been working hard to address the issues experienced during the last week. They have identified a series of three mitigation measures and put the first of these in place on Friday 3rd May.  If this does not resolve the problems, the second mitigation will be actioned, and then the third if necessary.

Please keep a lookout for any slowing down of the system or getting locked out. Please email myself, mbuchner@tactuum.com and onivarova@tactuum.com if you experience any problems, and also please raise an urgent support ticket via the Support Portal.

Thank you for your patience and understanding while we achieve a full resolution.

Promotion and communication resources

A rotating carousel presenting some of the key RDS tools and capabilities, and an editable slideset, are now available in the Resources for RDS providers section of the Learning and Support toolkit.

Redesign and improvements to RDS

The redesign of RDS Search and Browse is still on-track for delivery by mid-June 2024. We then plan to have a 3-week user acceptance testing phase before release to live. All editors and toolkit owners on this mailing list will be invited to participate in the UAT.

The archiving and version control functionality is also progressing well and we will advise on timescales for user acceptance testing shortly.

Tactuum is also progressing with the deep linking to individual toolkits within the mobile RDS app. There are several unknowns around the time and effort required for this work, which will only become clear as the work progresses. So we need to be careful to protect budget for this purpose.

New feature requests

These have all been compiled and effort estimated. Once the redesign work is complete, these will be prioritised in line with the remaining budget. We expect this to take place around late June.

Evaluation

Many thanks to those of you completed the value and impact survey we distributed in February. Here are some key findings from the 65 responses we received.

Figure 1: Impact of RDS on direct delivery of care

Key figures

  • 93% say that RDS has improved evidence-informed practice (high impact 62%; some impact 31%)
  • 91% report that RDS has improved consistency in practice (high impact 65%, some impact 26%)
  • 85% say that RDS has improved patient safety (high impact 59%, some impact 26%)
  • Although shared decision-making tools are only a recent addition to RDS, and only represent a small proportion of the current toolset, 85% of respondents still said that RDS had delivered impact in this area (53% high impact, 32% some impact.) 92% anticipate that RDS will deliver impact on shared decision-making in future and 85% believe it will improve delivery of personalised care in future.

Figure 2 shows RDS impact to date on delivery of health and care services

 

Key figures

These data show how RDS is already contributing to NHS reform priorities and supporting delivery of more sustainable care.

Saving time and money

  • RDS clearly has a strong impact on saving practitioner time, with 90% of respondents reporting that this is the case. 65% say it has a high impact; 25% say it has some impact on time-saving.
  • It supports devolved decision-making across the multi-professional team (85% of respondents)
  • 76% of respondents confirm that it saves money compared, for example, to investing in commercial apps (54% high impact; 22% some impact.)
  • 72% believe it has impacted already on saving money and reducing waste in the way services are delivered – e.g. reducing costs of referral management, prescribing, admissions.

Quality assurance and governance

  • RDS leads are clear that RDS has improved local governance of guidelines, with 87% confirming that this is the case. (62% high impact; 25% some impact.)

Service innovation and workforce development

  • RDS is a major driver for service innovation and improvement (83% of respondents) and has impacted significantly on workforce knowledge and skills (92% of respondents – 66% high impact; 26% some impact).

New toolkits

A few examples of toolkits published to live in the last month:

Toolkits in development

Some of the toolkits the RDS team is currently working on:

  • SARCS (Sexual Assault Response Coordination Service)
  • Staffing method framework – Care Inspectorate.
  • SIGN 171 - Diabetes in pregnancy
  • SIGN 158 – British Guideline on Management of Asthma. Selected sections will be incorporated into the RDS, and complemented by a new chronic asthma pathway being developed by SIGN, British Thoracic Society and NICE.
  • Clinical pathways from NHS Fife and NHS Lanarkshire

Please contact his.decisionsupport@nhs.scot if you would like to learn more about a toolkit. The RDS team will put you in touch with the relevant toolkit lead.

Quality audit of RDS toolkits

Thanks to all of you who have responded to the retrospective quality audit survey and to the follow up questions.  We still have some following up to do, and to work with owners of a further 23 toolkits to complete responses. An interim report is being presented to the HIS Quality and Performance Committee.

Implementation projects

Eight clinical services and two public library services are undertaking tests of change to implement the Being a partner in my care app. This app aims to support patients and the public to become active participants in Realistic Medicine. It has a strong focus on personalised, person-centred care and a library of shared decision aids, as well as simple explanations and videoclips to help the public to understand the aims of Realistic Medicine.  The tests of change will inform guidance and an implementation model around wider adoption and spread of the app.

With kind regards

Right Decision Service team

Healthcare Improvement Scotland

Caesarean Section (576)

Warning

Objectives

Caesarean Section (CS)– Clinical Guideline

This guideline provides information about procedural aspects of CS including preoperative and postoperative care – both for elective and emergency CS.

Please report any inaccuracies or issues with this guideline using our online form

Elective Caesarean Section

1. Booking an elective caesarean Section

The woman will be seen at the Obstetric ANC and a plan for delivery made. All CS should be discussed with the Obstetric Consultant. Consent for CS should be taken and filed in the case notes. Consent should be taken by Obstetric Consultant or Obstetric Trainee.  The Doctor authorizing the CS should ring delivery suite to book the CS – giving all relevant details (Indication, gestation, level of surgeon required, BMI, risk of bleeding, priority to go first, any anaesthetic or neonatal risks)

At the time of booking a preoperative appointment should be given to the woman.

All CS should be booked for >= 39 weeks unless there is an obstetric reason to be done earlier. If < 39 weeks steroids should be administered to decrease neonatal respiratory morbidity. The woman should be warned that occasionally her date for CS may require to be changed.

Details of the CS and pre-operative visit should be written on the CS information leaflet and this given to the woman.

 

2.   Preoperative assessment

Midwifery assessment should take place and the preoperative check list completed. If the maternal weight was not checked at 36 weeks then the woman should be weighed.

A FBC is performed if this was not taken at 36 weeks or if the result was abnormal. If blood will require to be crossmatched then this should be highlighted (GGC guideline Blood ordering schedule 2015) in the CS booklet.

The woman should be given oral ranitidine 150mg to be taken the night before and the morning of surgery. She should be given written information re admission and fasting times

The woman should attend the ERAS talk – given by midwifery, anaesthetic and physiotherapy staff.

 

3.   Admission for elective Caesarean Section

At PRM women are admitted to Ward 71 at 0730 on the day of their CS.
At QEUH they are admitted to ward 48 and to labour ward in RAH.

They are reviewed by the midwife – a full set of observations documented on the MOEWS chart and the fetal heart auscultated. Their most recent FBC should be reviewed. A group and save is performed on all women – those meeting the criteria are crossmatched (See- Blood Ordering Schedule – Obstetrics). If there are any antibodies on a previous G&S then this requires discussion with blood bank as to whether blood should be crossmatched prior to operation.

The Obstetrician planning to perform the CS should see the woman, confirm she still wishes to proceed, is appropriately consented and review the notes for any other additional surgical risk factors. They should then document this interaction in the notes.

All CS for breech should have an ultrasound performed to confirm the presentation.

The anaesthetic team for that day should also review each woman and document their findings.

 

4.   Elective Caesarean Section in Labour Ward

The team should all meet in theatre prior to the arrival of the first patient to introduce themselves and go through the list – identifying any surgical or anaesthetic risks, deciding whether neonates require to be present at delivery or whether cord bloods are required, deciding whether cell salvage would be useful and whether the surgeon wishes diathermy. The order of the list is then confirmed and the anaesthetist lets the pre-operative ward know who can have a drink and when. Women expected to wait longer than 2 hours for their operation should be considered for clear oral fluids. For longer lists, the anaesthetist may decide to allow a light breakfast for the last patient on the list.

The theatre midwife should check the woman’s details on her arrival in labour ward. She should explore the woman’s wishes re skin to skin, delayed cord clamping and seeing the baby being born.

In theatre the WHO checklist is completed. This includes identity of patient (name and CHI), allergies, consent, placental site, whether neonates or cord bloods are required. In PRM this is split into a sign in prior to anaesthesia and a time-out prior to skin incision. The entire team should be present and involved in the time out.

Once the patient is anaesthetised a urinary catheter is placed.

All women should receive antibiotic prophylaxis. One dose of co-amoxiclav 1.2gm( + amoxicillin 1 gm for women >80kg) or clindamycin 600 mg IV  and Gentamicin IV (penicillin allergy) should be given prior to skin incision (900mg clindamycin if woman >80kg and 1200mg of clindamycin if woman >120kg). A repeat dose of prophylactic antibiotics should be given during surgery if blood loss is more than 1.5 liters with Gentamicin being re-dosed at half prophylaxis dose (penicillin allergy).

There is no difference in maternal morbidity with different techniques of caesarean section including blunt vs sharp entry, single vs double layer closure of  uterus, exteriorisation of uterus for closure vs intrabdominal repair, closure vs non closure of parietal and pelvic peritoneum. (CORONIS trial 2016)

Delayed cord clamping of 1 minute should be performed if there are no concerns regarding the baby or maternal bleeding. Syntocinon administration should not be delayed until after cord clamping. (Delayed cord clamping in the term neonate GGC guideline)

5 units of syntocinon IV bolus should be given slowly after delivery of baby + 15 units of syntocinon in 500 ml crystalloid infusion over at least 30 minutes. Additional doses may be required for postpartum haemorrhage, antepartum haemorrhage, atonic uterus, placenta praevia, prolonged labour and multiple pregnancy. Consider using other uterotonics according to clinical condition.

Cord pH blood sampling should be performed if there is any concern regarding neonatal wellbeing. Perform both arterial and venous sampling.

At the end of the operation the sign-out section of the WHO checklist is performed – this includes confirmation of the swab and instrument check , the estimated/measured blood loss, confirmation if any extra antibiotics were given, analgesia and thromboprophylaxis prescribed, whether there were any specimens and instructions for recovery  (re syntocinon, oral fluids and tea and toast). The entire theatre team should be present and involved.

 

5. Post operative care:

Prior to leaving theatre skin to skin is resumed or initiated.

Women should be observed on a two to one basis (1:1 if GA) by a properly trained staff, observations (blood pressure, pulse, pain and sedation) should be done after every 5 minutes for 15 minutes then every 15 minutes for an hour and then hourly for four hours provided all observations are stable.

Any concerns should be directed to the obstetric or anaesthetic staff. Patients should not be discharged from recovery with any abnormal observations without prior medical review.

Emergency Caesarean Section

1. Decision for Emergency Caesarean Section

The time of decision to proceed to CS, the indication for CS and the Category should be clearly documented in the case notes and communicated to all staff.

 

2. Classification of Urgency of CS

Category 1 - Immediate threat to the life of the woman or fetus.

Category 2 - Maternal or fetal compromise which is not immediately life-threatening.

Category 3 - No maternal or fetal compromise but needs early delivery.

Category 4 - Delivery timed to suit woman or staff with no urgency to deliver.

Documentation of decision to delivery time is essential for all CS (categories 1-3).

Thirty minutes is a gold standard for decision to delivery interval for category 1 CS and for category 2 CS woman should be delivered within 75 minutes of making a decision.

 

3. Emergency CS procedure

Written consent should ideally be obtained. For some Category 1 CS verbal consent alone is appropriate but must be documented.

Bloods should be sent for FBC and G&S – if not already done.

Consider in utero resuscitation including stopping syntocinon, left lateral position, oxygen (only for maternal indication e.g. maternal hypoxia or preoxygenation), terbutaline 0.25 mg ( 0.5 ml in 1.0 ml ampoule) subcutaneous if contracting and IV fluids (Hartmann’s 1 litre rapid infusion unless fluid restricted e.g. preeclampsia). (Intrauterine fetal resuscitation GGC Guideline 3.2018). This should not delay transfer to theatre.

The decision regarding method of anaesthesia should be made by the anaesthetist after discussion with the obstetrician.

Once in theatre the urgency of the CS may require to be reclassified. Level 2 caesarean sections have an increased morbidity in part because deterioration may occur during the “wait for surgery”. Continued monitoring and re-evaluation of risk is an essential requirement.

The woman should not be left alone once the decision for a category 1 or 2 CS has been made.

If there is the potential for rapid labour progress a repeat vaginal examination should be performed in theatre prior to commencing the CS.

A neonatologist or ANNP should be asked to attend after giving information re indication and category for CS, gestation and any fetal concerns, using an SBAR format.

A surgical pause / WHO checklist should be performed prior to any CS.

The relevant antibiotics should be administered prior to the skin incision and the routine oxytocics after delivery of the baby.

Paired cord samples should be taken if there has been any suspected or proven fetal distress or if there is any concerns regarding the baby at birth.

The formal debrief should be completed prior to the woman leaving theatre, skin to skin initiated and then the woman transferred to recovery.

The surgeon should clearly document in the notes whether VBAC would be an option in a future pregnancy.

Care on the postnatal wards

Removal of the catheter should be carried out at 6-8 hours following elective CS and 12 hours after emergency CS. (Catheters should be removed 12 hours after CS). The timing of removal catheter should be documented together with the timing of the next void. ( Postpartum bladder care GGC guideline)

Prior to discharge home the IDL should be completed and any thromboprophylaxis and analgesia prescribed.

Indication for CS, the procedure and implications for future pregnancies should be discussed post-operatively prior to discharge home.

Editorial Information

Last reviewed: 01/10/2019

Next review date: 31/03/2023

Author(s): Judith Roberts.

Approved By: Obstetrics Clinical Governance Group

Document Id: 576

References

National Institute for Health and Clinical Excellence. Caesarean section NICE guideline CG 132.
Caesarean section surgical techniques (CORONIS) Lancet 382:9888 ; 234-248 2013